72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
06.06. - 09.06.2021
ePoster Montag, 07.06.2021
Neuroonkologie III/Neurooncology III
Meeting Abstract
(P053)
[Volltext]
A multi-omics approach to identify markers for glioblastoma recurrency
Schäfer A, Benescu AC, Evers L, Meier L, Nimsky C, Bartsch JW[Volltext]
Meeting Abstract
(P054)
[Volltext]
Analysis of influence of cortex temperature on patient cognition during awake-surgery – a pilot study
Knipps J, Kamp MA, Rapp M, Hänggi D, Sabel M[Volltext]
Meeting Abstract
(P055)
[Volltext]
AT101 – a specific therapy against glioma stem-like cells – mechanism of action in the microenvironment of the tumour
Hellmold D, Caylioglu D, Meyer R, Kubelt C, Synowitz M, Held-Feindt J[Volltext]
Meeting Abstract
(P056)
[Volltext]
Breaching the blood-brain Barrier (BBB) via Tumour Treating Fields (TTFields)
Salvador E, Keßler AF, Burek M, Brami CT, Voloshin-Sela T, Giladi M, Ernestus RI, Löhr M, Förster C, Hagemann C[Volltext]
Meeting Abstract
(P057)
[Volltext]
Carbonic Anhydrase XII blocking Antibody 6A10 can reduce ZEB1 and motility of glioblastoma stem cells
Chen TW, Nickel AC, Muhammad S, Hänggi D, Zeidler R, Kahlert UD, Martinez MV[Volltext]
Meeting Abstract
(P058)
[Volltext]
Characterisation of carbonic anhydrase 2 (CA-2) as a factor conferring temozolomide resistance in GBM stem cells
Zhao K, Culmsee C, Nimsky C, Bartsch JW[Volltext]
Meeting Abstract
(P059)
[Volltext]
Characterisation of heterogeneous antigen-expression pattern comparing glioblastoma cell lines, patient-derived cells and patients’ glioblastoma tissue
Dufner V, Schulz E, Monoranu C, Hudecek M, Hagemann C, Ernestus RI, Löhr M, Nerreter T[Volltext]
Meeting Abstract
(P060)
[Volltext]
CNS invasion in meningioma – detection by the surgeon and pathologist and its prognostic value
Behling F, Fodi C, Gepfner-Tuma I, Machetanz K, Renovanz M, Skardelly M, Bornemann A, Honegger J, Tabatabai G, Tatagiba M, Schittenhelm J[Volltext]
Meeting Abstract
(P061)
[Volltext]
Personalised treatment option in translational neuro-oncology – JAK/STAT-inhibition reverses myeloid cell-induced anti-tumour-immunity in T cells
Heiland DH, Ravi VM, Neidert N, Hofmann U, Beck J, Schnell O[Volltext]
Meeting Abstract
(P062)
[Volltext]
Quantification of PpIX-fluorescence of cerebral breast cancer metastases
Knipps J, Rapp M, Hänggi D, Sabel M, Kamp MA[Volltext]
Meeting Abstract
(P063)
[Volltext]
Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce
Vargas-Toscano A, Nickel AC, Li G, Kamp MA, Muhammad S, Leprivier G, Fritsche E, Barker RA, Sabel M, Steiger HJ, Zhang W, Hänggi D, Kahlert UD[Volltext]
Meeting Abstract
(P064)
[Volltext]
Reshaping the GBM landscape to enable targeting of chemo-resistant tumours
Joseph K, Maier J, Ravi VM, Beck J, Hofmann U, Schnell O, Heiland DH[Volltext]
Meeting Abstract
(P065)
[Volltext]
Evaluating the need for a regional virtual neurooncological tumour board – a survey study
Sommer B, Hackanson B, Konietzko I, Kahl KH, Stüben G, Berlis A, Maurer C, Märkl B, Schmid C, Trepel M, Shiban E[Volltext]
